Abolis Biotechnologies raised €35M in a round co-led by L’Oréal’s BOLD and Evonik VC, w/ DeepTech & Climate Fonds, Clay Capital, ICOS Capital, and Liberset.

Biotech Health services Manufacturing Pharma

Investments

01 September 2024

Abolis Biotechnologies (company)

Biotech Health services Manufacturing Pharma

Total investments received (USD): 38.5m

Round value (USD): 38.5m

Round investors: Evonik Venture Capital GmbH Icos Capital Management Clay Capital BOLD - Business Opportunities for L'Oréal Development Liberset DeepTech & Climate Fonds

Industry: Biotech Health services Manufacturing Pharma

Biotech Health services Manufacturing

Investments 06 February 2025

Beauty AI (big data) FMCG Food Industry Hardware Manufacturing Pharma Software Services Wearable

Investments 04 February 2025

Health services Manufacturing

Investments 03 February 2025

Health services Manufacturing Robotics

Investments 04 January 2025

Biotech Health services

Investments 10 December 2024